TargetedResponse

Dr. Milica Pešić, the PI of TartetedResponse, attended IBISS Biomedicine Research and Collaboration Capacity at Roche’s RISE Event.

Roche's initiative RISE hosted a one-day event in Ložionica, Beograd, on 27 September, aimed at bridging the gap between innovation in clinical practice and collaborative research. The programme featured several sessions tailored for experts in the field.

Session I focused on digital health innovations, showcasing contributions from Health Tech Lab and C4IR Serbia. In Session II, participants explored the integration of fundamental research with clinical applications, illustrated by studies from scientific institutes including IMGGE, IVI, IBISS, INEP, and IORS. Session III equipped attendees with strategic tools and methodologies for forming and securing funding for collaborative consortia, with insights from EUTA and the participation of BIO4 Campus representatives.

The achievements of IBISS were highlighted through presentations by Dr. Milica Pešić, Dr. Danijela Maksimović-Ivanić, Dr. Aleksandra Uskoković, and Dr. Aleksandra Mladenović, demonstrating their impactful contributions to the biomedical research in Serbia and beyond.

🔬 Throwback to some of the inspiring scientific meetings where team showcased our work!

📍 Zagreb, Croatia, 2024
Dr. Ana Podolski-Renić took the stage at The 7th HDIR Meeting, presenting how our research is bringing personalized therapy for NSCLC one step closer to clinical reality. 🧪🌍 (‘’Functional diagnostics in personalized therapy for non-small cell lung carcinoma’’)

📍 Belgrade, Serbia, 2024
At The 5th Belgrade Bioinformatics Conference (BelBI), Dr. Miodrag Dragoj presented our work on integrating functional diagnostics and bioinformatics for a smarter, more personalized approach to cancer treatment. 🧬💻 (‘’Integrating functional screening and bioinformatics for personalized medicine approaches in NSCLC‘’)
A great opportunity to showcase how data-driven science is transforming oncology research — right here in our hometown!

📍 Paris, France, 2023
Dr. Jelena Dinić represented the team at ESMO Open, presenting our findings on functional diagnostics and ex-vivo drug screening in NSCLC — paving the way for tackling multidrug resistance and advancing personalized therapy. 💊🧬(‘’Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy’’)

📍 Coimbra, Portugal, 2022
At The 5th Annual STRATAGEM Meeting, Dr. Miodrag Dragoj shared our vision on how functional diagnostics can revolutionize targeted cancer treatments. 🎯(‘’Functional diagnostics as a new concept for the improvement of personalized targeted therapy’’)

📢 The team has published a new article in Current Issues in Molecular Biology, focusing on personalized treatment strategy in non-small cell lung carcinoma (NSCLC).

🔗 Read the full article here: https://www.mdpi.com/1467-3045/47/4/281
-----------------------------------------
📢 Tim objavio je novi članak u časopisu Current Issues in Molecular Biology, koji se fokusira na personalizovani pristup u lečenju nesitnoćelijskog karcinoma pluća.

🔗 Pročitajte ceo članak ovde: https://www.mdpi.com/1467-3045/47/4/281